Skip to main content
. 2018 Aug 7;9:1081. doi: 10.3389/fphys.2018.01081

FIGURE 1.

FIGURE 1

Caveolae-specific CaMKII activation was detectable using phosphor-peptide tags. (A) Schematic diagram of a fusion protein comprised of the cytosolic domain of phospholamban (cPLN) and caveolin-3 (Cav3). (B) Phosphorylation at threonine 17 of the cytosolic domain of phospholamban in the fusion protein and endogenous phospholamban. The fusion protein comprised of cPLN and caveolin-3 (cPLN-Cav3) was expressed by adenoviral gene transfer in neonatal rat cardiomyocytes (NRCMs). After 15 min of β-adrenergic stimulation with isoproterenol (ISO) at the indicated concentration, cells were harvested and their protein extracts were prepared. The phosphorylation of phospholamban at threonine 17 (Thr17), the CaMKII-specific phosphorylation site, was assessed using a phospho-specific antibody for Thr17 of PLN, and its level was enhanced in a dose-dependent manner in both cPLN-Cav3 (upper arrow) and endogenous PLN (lower arrow). The membrane was re-probed using an anti-PLN antibody. (C) Schema of the proposed method for caveolae-specific CaMKII activation using a fusion protein and phospho-specific antibody. CaMKII activation induced by β-adrenergic stimulation provokes phosphorylation of cPLN-Cav3, which is localized in caveolae.